Chemoinformaics analysis of GLUCOSAMINE-SULFATE
| Molecular Weight | 277.251 | nRot | 5 |
| Heavy Atom Molecular Weight | 262.131 | nRig | 1 |
| Exact Molecular Weight | 277.047 | nRing | 0 |
| Solubility: LogS | -0.073 | nHRing | 0 |
| Solubility: LogP | -2.841 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 31.2399 |
| nHD | 7 | BPOL | 22.0021 |
| QED | 0.28 |
| Synth | 4.182 |
| Natural Product Likeliness | 2.091 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.172 |
| HIA | 0.79 |
| CACO-2 | -5.268 |
| MDCK | 0.00465902 |
| BBB | 0.161 |
| PPB | 0.246529 |
| VDSS | 0.555 |
| FU | 0.752902 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.024 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.076 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.143 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.02 |
| CL | 1.903 |
| T12 | 0.748 |
| hERG | 0.104 |
| Ames | 0.084 |
| ROA | 0.017 |
| SkinSen | 0.137 |
| Carcinogencity | 0.007 |
| EI | 0.017 |
| Respiratory | 0.393 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.766835 |